Heroin, cocaine, and alcohol addictions, alone and in combination, along with their frequent medical complications, including hepatitis B and C, AIDS, and psychiatric comorbidity, remain the major medical problems confronting our nation and much of the world. Effective treatments must be based on a fundamental understanding of the biological basis of each specific addictive disease, including the effects of exposure to drugs of abuse. Our NIH-NIDA Treatment Research Center will continue to identify and study the molecular, neurobiological, genetic and other biological correlates of the addictions, with focus on the role of the endogenous opioid system, and also factors which might affect treatment outcome. In this proposal for the continuation of our ongoing Center, all laboratory and clinical research studies have been developed on an interactive basis, relying upon the Center for their integration. Bidirectional translational research is the hallmark of the work of the Center. Research findings and observations from basic and applied clinical research are used to formulate specific hypotheses to be tested in laboratory research. Conversely, findings from laboratory research will be applied as promptly as feasible and appropriate, into clinical research, and then to the clinic. The specific projects proposed include: 1) effects of chronic opiates and cocaine, withdrawal, and challenge, on ultrastructure, receptors and gene expression of the endogenous opioid and related neurotransmitter systems; 2) effects of opiates and cocaine on the molecular biology and expression of the stress responsive hypothalamic-pituitary-adrenal axis; 3) biotransformation and pharmacodynamics of opioid and related neuropeptides: modulation of dopaminergic function and cocaine effects; 4) neuroendocrine effects of opiates and cocaine: role of the endogenous opioids and stress responsivity in addictive diseases; and 5) a conditional knockout of glutamatergic receptors involved in opioid and cocaine abuse. Scientific projects will be integrated through the eight Research Core resources, including a Research Training core, strengthening interactions to foster the synergism which only a Center can provide. We propose changing our P50 Specialized Center to a P60 Comprehensive Center because of increased training and information dissemination activities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Comprehensive Center (P60)
Project #
5P60DA005130-20
Application #
7092096
Study Section
Special Emphasis Panel (ZDA1-RXL-E (01))
Program Officer
Gordon, Harold
Project Start
1992-09-30
Project End
2007-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
20
Fiscal Year
2006
Total Cost
$3,048,429
Indirect Cost
Name
Rockefeller University
Department
Biology
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Gasser, Paul J; Hurley, Matthew M; Chan, June et al. (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913-1928
Butelman, Eduardo Roque; Bacciardi, Silvia; Maremmani, Angelo Giovanni Icro et al. (2017) Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? Am J Addict 26:632-639
Valenza, Marta; Picetti, Roberto; Yuferov, Vadim et al. (2016) Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. Neuropharmacology 105:639-650
Garzón, Miguel; Pickel, Virginia M (2016) Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum. J Comp Neurol 524:3084-103
Zhou, Yan; Leri, Francesco; Cummins, Erin et al. (2015) Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol Behav 139:127-35
Zhou, Y; Kreek, M J (2015) Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic ""binge"" pattern escalating-dose, but not steady-dose, cocaine. Neuroscience 289:63-70
Zhou, Yan; Kreek, Mary Jeanne (2014) Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation. Neuropharmacology 87:51-8
Mayer-Blackwell, B; Schlussman, S D; Butelman, E R et al. (2014) Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression. Neuroscience 258:280-91
Lawhorn, Collene; Yuferov, Vadim; Randesi, Matthew et al. (2013) Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations. Cytokine 64:571-6
Yuferov, Vadim; Ho, Ann; Morgello, Susan et al. (2013) Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment. J Neuroimmune Pharmacol 8:333-44

Showing the most recent 10 out of 168 publications